Browsing U.S. Classifications

• All Classifications
  • 435: CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY
    • 435/325: ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE
      • 435/326: Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof
        • 435/327: Immunoglobulin or antibody is anti-idiotypic
        • 435/328: Immunoglobulin or antibody is chimeric, mutated, or a recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobuin fusion protein, etc.)
        • 435/329: Immunoglobulin or antibody binds an oligosaccharide structure other than nucleic acid
        • 435/330: Immunoglobulin or antibody binds an expression product of a cancer related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.)
        • 435/331: Immunoglobulin or antibody binds a specifically identified amino acid sequence
        • 435/332: Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.)
        • 435/345: Immunoglobulin or antibody binds a drug, hapten, hapten-carrier complex, or specifically identified chemical structure (e.g., theophylline, digoxin, etc.)

Results display:

Refine search:

You need to login or signup to refine your search

Login | Signup

1-10 of 1,642 patent results

Analyze results
w/charts & graphs

Email me
new matches

Add results on
this page to list

Add ALL
results to list

Export
results

Amphiphilic imidazolinium derivatives U.S. Patent US5736395 | Filed: 05/19/1997 | Issued: 04/07/1998 Assignee(s): Megabios Corporation | Inventor(s): Timothy D. Heath + 1 | Agent(s): McDonnell Boehnen Hulbert & Berghoff | Examiner(s): Floyd D. Higel Amphiphiles containing an imidazdinium ring system are provided that are non-toxic to the host mammal. The amphiphiles are used to produce liposomes useful as carriers for delivering macromolecules...

Method for culturing t lineage precursor cells under conditions of high oxygen concentration U.S. Patent US5792655 | Filed: 09/11/1995 | Issued: 08/11/1998 Assignee(s): Japan Tobacco, Inc. | Inventor(s): Yoshihiro Watanabe | Agent(s): Birch, Stewart, Kolasch & Birch, LLP | Examiner(s): Marian C. Knode The present invention provides culture methods of T lineage precursor cells comprising a step of culturing the T lineage precursor cells under a condition that a dissolved oxygen concentration in t...

Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens U.S. Patent US5994126 | Filed: 06/17/1994 | Issued: 11/30/1999 Assignee(s): The Rockefeller University | Inventor(s): Ralph M. Steinman + 2 | Agent(s): Morgan & Finnegan, L.L.P. | Examiner(s): Lankford, Jr.; Leon B. A method for producing proliferating cultures of dendritic cell precursors is provided. Also provided is a method for producing mature dendritic cells in culture from the proliferating dendritic ce...

Monoclonal antibodies to ceftiofur U.S. Patent US5908781 | Filed: 12/10/1996 | Issued: 06/01/1999 Assignee(s): The United States of America as represented by the Secretary of Agriculture | Inventor(s): Larry H. Stanker + 3 | Agent(s): Randall E. Deck | Examiner(s): Lila Feisee Hybridoma cell lines have been generated which produce and secrete monoclonal antibodies which selectively bind to the ceftiofur. These hybridomas may be obtained by using as an immunization agent ...

Monoclonal antibody to human mx protein mxa U.S. Patent US6180102 | Filed: 10/02/1998 | Issued: 01/30/2001 Assignee(s): Kyowa Hakko Kogyo Co., Ltd. + 1 | Inventor(s): Nobuo Hanai + 4 | Agent(s): Nixon & Vanderhye P.C. | Examiner(s): Marianne P. Allen This invention provides a monoclonal antibody which recognizes an epitope corresponding to amino acids 10 to 220, amino acids 221 to 297, or amino acids 469 to 662, counting from the N-terminus of ...

Anti-fas ligand antibody and assay method using the anti-fas ligand antibody U.S. Patent US6114507 | Filed: 05/17/1996 | Issued: 09/05/2000 Assignee(s): Mochida Pharmaceutical Co., Ltd. + 1 | Inventor(s): Kamon Shirakawa + 4 | Agent(s): Birch, Stewart, Kolasch & Birch, LLP | Examiner(s): Jeffrey Stucker An anti-Fas ligand antibody capable of suppressing Fas ligand-induced apoptosis to a high degree, especially humanized antibodies having less antigenecity to human, and a method for assaying the Fa...

Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody U.S. Patent US6228360 | Filed: 08/19/1998 | Issued: 05/08/2001 Assignee(s): Ajinomoto Co., Inc. | Inventor(s): Man Sung Co + 1 | Agent(s): Oblon, Spivak, McClelland, Maier & Neustadt, P.C. | Examiner(s): Phillip Gambel Anti-thrombotic agents containing humanized antibodies which bind to von Willebrand factor.

Ip-10/mig receptor designated cxcr3, antibodies, nucleic acids, and methods of use therefor U.S. Patent US6184358 | Filed: 03/31/1997 | Issued: 02/06/2001 Assignee(s): Millennium Pharmaceuticals, Inc. + 1 | Inventor(s): Marcel Loetscher + 3 | Agent(s): Hamilton, Brook, Smith & Reynolds, P.C. | Examiner(s): Prema Mertz The present invention relates to proteins or polypeptides, referred to herein as isolated and/or recombinant mammalian (e.g., human) IP-10/Mig receptor proteins designated CXC Chemokine Receptor 3 ...

Humanized antibodies reactive with l-selectin U.S. Patent US6210671 | Filed: 12/27/1995 | Issued: 04/03/2001 Assignee(s): Protein Design Labs, Inc. | Inventor(s): Man Sung Co | Agent(s): Townsend & Townsend & Crew | Examiner(s): Phillip Gambel Humanized immunoglobulins specifically reactive with L-selectin are prepared employing recombinant DNA technology for use in e.g., treatment of inflammatory disorders.

Transgenic non-human animals for producing heterologous antibodies U.S. Patent US6300129 | Filed: 12/02/1996 | Issued: 10/09/2001 Assignee(s): GenPharm International | Inventor(s): Nils Lonberg + 1 | Agent(s): Townsend & Townsend & Crew | Examiner(s): Karen M. Hauda The invention relates to transgenic non-human animals capable of producing heterologous antibodies and methods for producing human sequence antibodies which bind to human antigens with substantial ...

Your search results have been limited to the top 10. Subscribe to Boliven PRO to access full search results